Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.81 |
| ▸ | GAA | P10253 | 1/20 | 0.81 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.80 |
| ▸ | THRB | P10828 | 5/20 | 0.80 |
| ▸ | LMNA | P02545 | 3/20 | 0.80 |
| ▸ | MAPT | P10636 | 3/20 | 0.80 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.80 |
| ▸ | THRA | P10827 | 1/20 | 0.76 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.67 |
| ▸ | HRH2 | P25021 | 4/20 | 0.64 |
| ▸ | HRH1 | P35367 | 4/20 | 0.64 |
| ▸ | HRH3 | Q9Y5N1 | 4/20 | 0.62 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.62 |
| ▸ | CHRM2 | P08172 | 2/20 | 0.62 |
| ▸ | HTR2A | P28223 | 2/20 | 0.62 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.62 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.62 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.62 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.62 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11222638 | 0.90 | THRB (0.97) | SMN1; SMN2GAAALDH1A1THRBLMNA | |
| SCHEMBL10107798 | 0.90 | THRB (0.88) | SMN1; SMN2GAAALDH1A1THRBLMNA | |
| SCHEMBL12670301 | 0.90 | SMN1; SMN2 (1.00) | SMN1; SMN2GAAALDH1A1THRBLMNA | |
| SCHEMBL863278 | 0.88 | THRB (0.78) | SMN1; SMN2GAAALDH1A1THRBLMNA | |
| SCHEMBL29508033 | 0.88 | THRB (0.84) | SMN1; SMN2GAAALDH1A1THRBLMNA | |
| SCHEMBL14287618 | 0.87 | THRB (0.81) | SMN1; SMN2ALDH1A1THRBLMNAMAPT | |
| SCHEMBL21663339 | 0.86 | THRB (1.00) | SMN1; SMN2GAAALDH1A1THRBLMNA | |
| SCHEMBL21641953 | 0.86 | THRB (1.00) | SMN1; SMN2GAAALDH1A1THRBLMNA | |
| SCHEMBL4687379 | 0.84 | SMN1; SMN2 (0.76) | SMN1; SMN2GAAALDH1A1THRBLMNA | |
| SCHEMBL4455251 | 0.84 | ALDH1A1 (0.92) | SMN1; SMN2GAAALDH1A1THRBLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2619184-B1 | DEUBIQUITINASE INHIBITORS AND METHODS FOR USE OF THE SAME | UNIV MICHIGAN REGENTS (US) | 2018-05-23 | — | — | EP | disclosed |
| US-20140357673-A1 | Deubiquitinase Inhibitors and Methods for Use of the Same | UNIV MICHIGAN (US) | 2014-12-04 | — | — | US | disclosed |
| US-8809377-B2 | Deubiquitinase inhibitors and methods for use of the same | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2014-08-19 | — | — | US | disclosed |
| US-20120077806-A1 | Deubiquitinase Inhibitors and Methods for Use of the Same | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2012-03-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140357673-A1 | Deubiquitinase Inhibitors and Methods for Use of the Same | UCHL1, USP2, USP1 | SMN1; SMN2 203/4885GAA 72/4885ALDH1A1 2619/4885 |
| US-20120077806-A1 | Deubiquitinase Inhibitors and Methods for Use of the Same | UCHL1, USP2, USP1 | SMN1; SMN2 203/4885GAA 72/4885ALDH1A1 2619/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.